We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples

By LabMedica International staff writers
Posted on 19 Apr 2023
Print article
Image: Indole-3-propionic acid has emerged as an emerging indicator of gut health (Photo courtesy of Freepik)
Image: Indole-3-propionic acid has emerged as an emerging indicator of gut health (Photo courtesy of Freepik)

Digestive disorders represent a significant health burden in our society, with chronic gut inflammation and microbial imbalances playing a critical role in obesity, cardio-metabolic diseases, premature aging, and cancer. Indole-3-propionic acid (IPA), a small metabolite generated by human gut bacteria, has emerged as a vital marker of gut health due to its regulation of the gut's immune response and suppression of excessive inflammation. Patients experiencing active gut inflammation exhibit reduced IPA levels, while recovery from inflammation leads to a restoration of IPA concentrations. Now, researchers are developing the first-ever sensor for the instant detection of IPA in blood serum and stool samples.

A research team from the Singapore-MIT Alliance for Research and Technology (SMART, Singapore) plans to use portable spectrometers previously developed by SMART's Disruptive & Sustainable Technologies for Agricultural Precision (DiSTAP) for other biological applications like non-invasive plant health monitoring, to quickly measure IPA levels in blood or stool samples. This advancement will streamline the testing process since traditional IPA analysis involves conventional mass spectrometry-based methods and specialized laboratory equipment.

“Nutrition, microbiome and anti-inflammatory approaches have received great attention in recent years and are hailed as some of the most promising research areas that will address the country’s healthcare challenges,” said Dr. Mervin Chun-Yi Ang, SMART DiSTAP Associate Scientific Director. “Building on SMART DiSTAP’s success in customising portable spectrometers for different agricultural applications, we are excited to further develop these tools and see how they can be also applied to healthcare and medicine.”

Related Links:
SMART 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.